M. Seol

Je-Hwan Lee, Jung-Hee Lee, K. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study

J. Chung, K. Ahn, Y. S. Lee, 2010, Bone Marrow Transplantation.

Randomized comparison of four-times-daily versus once-daily intravenous busulfan in conditioning therapy for hematopoietic cell transplantation.

S. Yun, G. Noh, S. Han, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Stem Cell TransplantationResearch Paper

S. Yun, Je-Hwan Lee, Jung-shin Lee, 2005 .

Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.

S. Yun, Je-Hwan Lee, Jung-shin Lee, 2005, Haematologica.

Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia.

Yeonhee Kim, Je-Hwan Lee, Jung-Hee Lee, 2018, Leukemia research.

Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5 %—a feasibility study

Je-Hwan Lee, Dae-Young Kim, Jung-Hee Lee, 2016, Annals of Hematology.

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity

S. Yun, S. Jang, H. Chi, 2010, Bone Marrow Transplantation.

Monosomal karyotype in acute myeloid leukemia and the role of allogeneic hematopoietic cell transplantation

Young-Uk Cho, Yunsuk Choi, Je-Hwan Lee, 2015, Annals of Hematology.

Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.

Je-Hwan Lee, Dae-Young Kim, Jung-Hee Lee, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

S. Sohn, Je-Hwan Lee, Jung-shin Lee, 2004, Haematologica.

Pre‐engraftment graft‐versus‐host disease after allogeneic hematopoietic cell transplantation for acute leukemia

Yunsuk Choi, Je-Hwan Lee, Dae-Young Kim, 2011, European journal of haematology.

Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation

H. Chi, S. Kim, M. Seol, 2003, Bone Marrow Transplantation.

Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome.

S. Yun, Sung‐Han Kim, Je-Hwan Lee, 2011, Blood.

Clinical effect of reduced‐intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated‐donors

W. Lee, Y. Joo, Je-Hwan Lee, 2011, American journal of hematology.

Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors

Je-Hwan Lee, Jung-Hee Lee, K. Lee, 2018, Leukemia & lymphoma.

C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia.

Je-Hwan Lee, H. Chi, Chan-Jeoung Park, 2008, Leukemia research.

Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia.

S. Yun, Soo-yeon Park, I. Choi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Single nucleotide polymorphism of Wilms’ tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia

Yunsuk Choi, Hyeong-Seok Lim, Je-Hwan Lee, 2012, Annals of Hematology.

Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation.

K. H. Lee, J. Lee, S. Kim, 2001, Leukemia research.

Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.

S. Yun, J. Jo, Yunsuk Choi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogenetics.

Je-Hwan Lee, Sol Kang, H. Chi, 2009, Leukemia research.

Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation study.

Y. Yeom, I. Choi, Je-Hwan Lee, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation

J. Jo, Yunsuk Choi, Je-Hwan Lee, 2020, Clinical transplantation.

Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.

S. Yun, Je-Hwan Lee, S. Jang, 2009, Leukemia research.

A prediction model for complete remission upon reinduction for patients with acute myeloid leukemia after failure of anthracycline and cytarabine standard chemotherapy

S. Yun, Yunsuk Choi, S. Sym, 2011, Annals of Hematology.

Risk score model for fatal intracranial hemorrhage in acute leukemia

Y. S. Lee, H. Kim, M. Seol, 2006, Leukemia.

Symptom and Interference of Activities of Daily Living of Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums

Jeong Hye Kim, J. Park, S. Lee, 2013 .

Androgen therapy for patients with lower‐risk myelodysplastic syndrome and significant cytopenia: a retrospective study

Je-Hwan Lee, Jung-Hee Lee, K. Lee, 2019, British journal of haematology.